Metraipolis › archive › dc_e10d6000bf5b
Influenza Virus: Global Health Impact, Strategies, Challenges, Role of Nanotechnolgy in Influenza Vaccine Development — Europe PMC PMID:41012096
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41012096
- DOI
- 10.3390/vaccines13090890
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T10:24:45.732Z
- SHA-256 of the archived text
c217c2e89d0fb04e4337feeead263d0da2bc8215b3e8f20f7f5541874859a4bc- Stable URL of this page
https://metraipolis.com/documento/dc_e10d6000bf5b
How to cite
Influenza Virus: Global Health Impact, Strategies, Challenges, Role of Nanotechnolgy in Influenza Vaccine Development — Europe PMC PMID:41012096 — Europe PMC (en), https://europepmc.org/article/MED/41012096 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e10d6000bf5b (Metraipolis archive dc_e10d6000bf5b, sha256 c217c2e89d0fb04e4337feeead263d0da2bc8215b3e8f20f7f5541874859a4bc)
BibTeX
@misc{dce10d6000bf5b,
title = {Influenza Virus: Global Health Impact, Strategies, Challenges, Role of Nanotechnolgy in Influenza Vaccine Development — Europe PMC PMID:41012096},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41012096},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e10d6000bf5b; sha256 c217c2e89d0fb04e4337feeead263d0da2bc8215b3e8f20f7f5541874859a4bc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012096. Agents can read the archived copy with the MCP tool read_document.